VEINAMINE 8% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Veinamine 8%, and what generic alternatives are available?
Veinamine 8% is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for VEINAMINE 8%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VEINAMINE 8% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VEINAMINE 8%
US Patents and Regulatory Information for VEINAMINE 8%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | VEINAMINE 8% | amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate | INJECTABLE;INJECTION | 017957-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |